Maternal immune activation: A critical prenatal risk factor for autism spectrum disorder
Bo Yuan1, Aihua Yuan2, Minjia Lu3
1Institute of Medical Genetics and Genomics, Fudan University, Shanghai 200032, China.
Maternal immune activation (MIA) is an important prenatal risk factor for autism spectrum disorder (ASD). This commentary summarizes epidemiological and experimental evidence linking MIA to altered fetal neurodevelopment, highlighting placental mechanisms, long-term immune programming, sex-related risk and resilience, and potential strategies to monitor and manage pregnancies with significant maternal inflammation.
Maternal immune activation (MIA) is an important prenatal risk factor for autism spectrum disorder (ASD). This commentary summarizes epidemiological and experimental evidence linking MIA to altered fetal neurodevelopment, highlighting placental mechanisms, long-term immune programming, sex-related risk and resilience, and potential strategies to monitor and manage pregnancies with significant maternal inflammation.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Gut-Brain Axis
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Development of the Oral Microbiota


